Expression and Characterization of a Divalent Chimeric Anti-Human CD3 Single Chain Antibody

Scandinavian Journal of Immunology

Volumn 43, Issue 2, 1996, Pages 134-139

  Ma, Shenglin ^a   Thompson, J ^a   Hu, Huaizhong ^a   Neville Jr , D M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CHIMERIC ANTIBODY; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; OKT 3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, CD3; BASE SEQUENCE; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN M; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030088128     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-22.x     Document Type: Article

References (30)

1. Parlevliet KJ, Schellekens PTA. Monoclonal antibodies in renal transplantation: a review. Transplant Int 1992;5:234-46.
2. Cosimi AB, Burton RC, Colvin RB et al. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 1981;32:535-9.
3. Jaffers GJ, Fuller TC, Cosimi AB, Russell PS, Winn HJ, Colvin RB. Monoclonal antibody therapy: anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation 1986;41:572-8.
4. Abramowicz D, Schandene L, Goldman M et al. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 1989;47:606-8.
5. Burns GF, Boyd AW, Beverley PC. Two monoclonal anti-human T lymphocyte antibodies have similar biologic effects and recognize the same cell surface antigen. J Immunol 1982; 129:1451-7.
6. Parren PW, Geerts MEJ, Boeije LCM, Aarden LA. Induction of T cell proliferation by recombinant mouse and chimeric mouse/ human anti-CD3 monoclonal antibodies. Res Immunol 1991;142:749-63.
7. Waid TH, Lucas BA, Thompson JS et al. Treatment of acute rejection with anti-T cell antigen receptor complex alpha/beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial. Transplant Proc 1991;23:1062-5.
8. Khazaeli MB, Conry RM, Lobuglio AF. Human immune response to monoclonal antibodies. J Immunotherapy 1994;15:42-52.
9. Shalaby MR, Shepard HM, Presta L et al. Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 proto-oncogene. J Exp Med 1992;175:217-25.
10. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987;7:2745-52.
11. 2 domain-deleted recombinant immunoglobulin. Int J Cancer 1993;53:97-103.
12. Rigaut KD, Scharff JE, Neville DM Jr. Selective killing of T cells by immunotoxins directed at distinct Vβ epitopes of the TCR. Eur J Immunol 1995;25:2077-82.
13. Woodle ES, Thistlethwaite JR, Jolliffe LK et al. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J Immunol 1992;148:2756-63.
14. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989;7:980-90.
15. Shu LM, Qi CF, Schlom J, Kashmiri SVS. Secretion of a single-gene- encoded immunoglobulin from myeloma cells. Proc Natl Acad Sci USA 1993;90:7995-9.
16. Mosmann TR, Williamson AR. Structural mutations in a mouse immunoglobulin light chain resulting in failure to be secreted. Cell 1980;20:283-92.
17. Capon DJ, Chamow SM, Mordenti J et al. Designing CD4 immunoadhesions for AIDS therapy. Nature 1989;337:525-31.
18. Anand NN, Mandai S, MacKenzie CR et al. Bacterial expression and secretion of various single-chain Fv genes encoding proteins specific for a Salmonella serotype B O-antigen. J Bio Chem 1991;266:21874-9.
19. Sitia R, Neuberger M, Alberini CM et al. Developmental regulation of IgM secretion: the role of the carboxyl-terminal cysteine. Cell 1990;60:781-90.
20. Alberini CM, Bet P, Milstein C, Sitia R. Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents. Nature 1990;347:485-7.
21. Fra AM, Fragioli C, Finazzi D, Sitia R, Alberini CM. Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation. The EMBO Journal 1993;12:4755-61.
22. Wiersma EJ, Shulman MJ. Assembly of IgM: Role of disulphide bonding and noncovalent interactions. J Immunol 1995;154:5265-72.
23. Smith KG, Austyn JM, Hariri G, Beverley PC, Morris PJ. T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors. Eur J Immunol 1986;16:478-86.
24. Tax WJ, Hermes FF, Willems RW, Capel PJ, Koene RA. Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation. J Immunol 1984;133:1185-9.
25. Lynch, RG, Sandor M. Fc receptors on T and B lymphocytes. In: Metzger H, ed. Fc Receptors and the Action of Antibodies. Washington DC: American Society for Microbiology, 1990:305-34.
26. Moretta I, Webb SR, Grossi CE, Lydyard M, Cooper MD. Functional analysis of human subpopulations: help and suppression of B cell responses by T cells bearing receptors for IgM or IgG. J Exp Med 1977;146:184-200.
27. Ferrarini M, Moretta L, Mingari MC, Tonda P, Pernis B. Human T cell receptor for IgM: specificity for the pentameric Fc fragment. Eur J Immunol 1976;6:520-1.
28. Mathur A, Lynch RG, Kohler G. The contribution of constant region domain to the binding of murine IgM to Fc mu receptors on T cells. J Immunol 1988;140:143-7.
29. Pricop L, Rabinowich H, Morel PA, Sulica A, Whiteside TL, Herberman RB. Characterization of the Fcμ receptor on human natural killer cells. J Immunol 1993;151:3018-29.
30. Emara M, Sanfilippo F. The inhibition of T cell proliferative responses by crosslinking CD7 and IgM-Fc receptors. Cell Immunol 1992;144:143-54.